# Hour 13 PSL Scores: 13:00-13:59

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## PSL Scores at End of Hour 13

| Robot Type | Dim A (Omniscient) | Dim B (Omnipresent) | Dim C (Omnipotent) | PSL | Delta | Band |
|-----------|-------------------|--------------------|--------------------|-----|-------|------|
| Surgical Robots | 7.3 | 5.9 | 7.6 | 6.9 | +0.0 | Advanced |
| Cobots | 7.1 | 6.6 | 6.3 | 6.7 | +0.0 | Advanced |
| RT Positioning | 7.6 | 6.1 | 6.9 | 6.9 | +0.0 | Advanced |
| Needle-Placement | 6.9 | 5.6 | 6.6 | 6.4 | +0.0 | Advanced |
| Social Companion | 5.7 | 7.3 | 4.1 | 5.7 | +0.1 | Intermediate |
| Humanoids | 5.9 | 6.1 | 5.3 | 5.8 | +0.0 | Intermediate |
| RT Motion-Tracking | 7.9 | 6.3 | 7.1 | 7.1 | +0.0 | Advanced |
| Imaging Assistant | 7.1 | 6.9 | 5.9 | 6.6 | +0.0 | Advanced |
| Steerable Needle | 7.3 | 5.3 | 7.1 | 6.6 | +0.0 | Advanced |
| Rehab Exoskeletons | 5.6 | 5.9 | 5.6 | 5.7 | +0.0 | Intermediate |

## Cumulative Site PSL: 64.9 (Advanced Site)

Prior hour cumulative: 64.8. Change this hour: +0.1.

## Scoring Justification (Hour 13)

### Social Companion - Dimension A Change: 5.6 to 5.7 (+0.1)

The Dimension A (Omniscient) increase for Social Companion robots reflects
improved pediatric anxiety pattern recognition demonstrated during the
PAT-ODMND-0100 engagement. Specifically:

- COMPN-01 detected the 9-year-old ALL patient's anxiety state through
  combined facial cue analysis and voice tremor detection at session onset.
- The adaptive algorithm correctly identified the transition point where
  story narration complexity could be increased, correlating with decreasing
  physiological anxiety markers (heart rate drop from 92 to 80 bpm).
- Port access timing was optimized based on the real-time anxiety score
  (intervention when score reached 3/10), resulting in minimal distress
  (Faces Pain Scale 2/10).
- This pattern recognition capability generalizes across the companion fleet:
  COMPN-01 through COMPN-05 share the updated anxiety detection model via
  federated learning update at 13:55.

The +0.1 increase is conservative, reflecting a single successful
demonstration in a single pediatric case. Further validation across
additional pediatric encounters is needed before a larger increment is
warranted.

### All Other Scores - No Change

Remaining robot types maintained their prior-hour PSL scores. While Hour 13
saw extensive activity across all 10 types with 17 of 29 instances active,
no individual robot type demonstrated a performance capability beyond its
previously established level. Performance was consistent with expectations:

- Surgical Robots: SURG-03 operating at established capability with standard
  force feedback, margin detection, and instrument coordination. The
  mediastinal tumor excision proceeds within documented parameters.
- Cobots: COBOT-03 biopsy completed with standard probe pressure and needle
  guidance accuracy consistent with prior demonstrations.
- RT Positioning: RTPOS-01 achieved 0.4 mm positioning accuracy, consistent
  with the established 6-DOF capability and prior SRS sessions.
- Needle-Placement: NEEDLE-02 maintained 0.8 mm trajectory accuracy near the
  facial nerve, within the established submillimeter guidance envelope.
- Humanoids: HUMAN-02 demonstrated standard exercise guidance and emotional
  support capabilities. Engagement score of 8/10 consistent with prior
  pediatric rehabilitation sessions.
- RT Motion-Tracking: TRACK-03 delivered 2.000 Gy with 93.8% gating
  efficiency. TRACK-01 in calibration phase only.
- Imaging Assistant: IMAGE-03 achieved 8.5/10 image quality and 94% coverage,
  consistent with established performance.
- Steerable Needle: STEER-02 demonstrated 0.6 mm tip tracking accuracy during
  the insertion phase, consistent with prior ablation sessions.
- Rehab Exoskeletons: REHAB-02 in calibration phase only; insufficient data
  for score adjustment.

### Dimension Definitions

- Dimension A (Omniscient): The robot's ability to sense, perceive, and
  understand its environment and the patient's clinical state in real time.
- Dimension B (Omnipresent): The robot's ability to be available across
  multiple locations, patients, or simultaneous tasks.
- Dimension C (Omnipotent): The robot's ability to perform clinical actions
  with precision, range, and effectiveness.

## USL Comparison Note

The USL framework (Kawchak, 2026; DOI: 10.5281/zenodo.18778220) evaluates
robot technical interoperability. Key USL scores for reference:

| Robot Platform | USL Score | PSL Score (this sim) |
|---------------|-----------|---------------------|
| da Vinci dVRK | 7.1 | 6.9 (Surgical) |
| Franka Panda | 7.4 | 6.7 (Cobot) |
| Boston Dynamics Atlas | 5.8 | 5.8 (Humanoid) |

PSL and USL measure different aspects: USL focuses on technical unification
readiness while PSL focuses on clinical trial performance (omniscience,
omnipresence, omnipotence). At Hour 13 with 58% site utilization, the
correlation between USL and PSL remains moderate. High-throughput conditions
do not inherently shift PSL scores; demonstrated capability improvements
(such as the Companion Dim A increase) are required.

The single-patient cancer journey framework (Kawchak, 2026;
DOI: 10.5281/zenodo.19119939) established PSL scoring methodology for
individual patient encounters. Hour 13 applies this methodology across
22 concurrent patients, validating that PSL scoring scales to multi-patient
on-demand environments without loss of per-robot granularity.
